Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
HumanPhenoMyelofibrosis

MPL TBXAS1 TET2 SH2B3

7.52e-0613544HP:0011974
HumanPhenoMegakaryocyte nucleus hyperlobulation

MPL TET2 SH2B3

2.20e-056543HP:0031388
DomainIG

ADAMTSL1 KIR2DS2 NFASC PAPLN LY6G6F PTPRF IL1R2 PXDNL WFIKKN1 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 LRIT1

6.88e-0642116915SM00409
DomainIg_sub

ADAMTSL1 KIR2DS2 NFASC PAPLN LY6G6F PTPRF IL1R2 PXDNL WFIKKN1 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 LRIT1

6.88e-0642116915IPR003599
Domain-

MPL ADAMTSL1 KIR2DS2 NFASC PAPLN LY6G6F PTPRC PTPRF UMODL1 IL1R2 PXDNL WFIKKN1 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 PLXNB3 LRIT1

9.32e-06663169192.60.40.10
DomainEGF

TPO NID2 FRAS1 PGAP6 CD93 THBS1 OIT3 UMODL1 CSPG5 ADGRE1 MUC3A

1.00e-0523516911SM00181
DomainEGF_3

TPO NID2 SSPOP PGAP6 CD93 THBS1 OIT3 UMODL1 CSPG5 ADGRE1 MUC3A

1.00e-0523516911PS50026
DomainVWFC_1

FRAS1 SSPOP THBS1 PXDNL CHRD

1.72e-05361695PS01208
DomainEGF-like_dom

TPO NID2 FRAS1 PGAP6 CD93 THBS1 OIT3 UMODL1 CSPG5 ADGRE1 MUC3A

1.72e-0524916911IPR000742
DomainIg-like_fold

MPL ADAMTSL1 KIR2DS2 NFASC PAPLN LY6G6F PTPRC PTPRF UMODL1 IL1R2 PXDNL WFIKKN1 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 PLXNB3 LRIT1

2.24e-0570616919IPR013783
DomainVWFC_2

FRAS1 SSPOP THBS1 PXDNL CHRD

2.25e-05381695PS50184
DomainVWC

FRAS1 SSPOP THBS1 PXDNL CHRD

2.25e-05381695SM00214
DomainEGF_2

TPO NID2 SSPOP PGAP6 CD93 THBS1 OIT3 UMODL1 CSPG5 ADGRE1 MUC3A

3.05e-0526516911PS01186
DomainVWF_dom

FRAS1 SSPOP THBS1 PXDNL CHRD

3.71e-05421695IPR001007
DomainIG_LIKE

ADAMTSL1 KIR2DS2 NFASC PAPLN LY6G6F PTPRF IL1R2 PXDNL WFIKKN1 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 LRIT1

4.15e-0549116915PS50835
DomainIg-like_dom

ADAMTSL1 KIR2DS2 NFASC PAPLN LY6G6F PTPRF IL1R2 PXDNL WFIKKN1 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 LRIT1

5.46e-0550316915IPR007110
Domainig

KIR2DS2 NFASC IL1R2 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 LRIT1

5.95e-051901699PF00047
DomainImmunoglobulin

KIR2DS2 NFASC IL1R2 VSTM2L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 LRIT1

5.95e-051901699IPR013151
DomainVWC

FRAS1 THBS1 PXDNL CHRD

1.12e-04281694PF00093
DomainEGF_CA

TPO NID2 CD93 THBS1 OIT3 UMODL1 ADGRE1

1.23e-041221697SM00179
DomainEGF_CA

TPO NID2 CD93 THBS1 UMODL1 ADGRE1

1.30e-04861696PF07645
DomainEGF-like_Ca-bd_dom

TPO NID2 CD93 THBS1 OIT3 UMODL1 ADGRE1

1.36e-041241697IPR001881
DomainEGF_Ca-bd_CS

TPO NID2 CD93 OIT3 UMODL1 ADGRE1

2.51e-04971696IPR018097
DomainEGF_CA

TPO NID2 CD93 OIT3 UMODL1 ADGRE1

2.81e-04991696PS01187
DomainASX_HYDROXYL

TPO NID2 CD93 OIT3 UMODL1 ADGRE1

2.97e-041001696PS00010
DomainWAP

UMODL1 WFIKKN1 WFDC5

3.74e-04161693SM00217
DomainWAP

UMODL1 WFIKKN1 WFDC5

3.74e-04161693PF00095
DomainEGF-type_Asp/Asn_hydroxyl_site

TPO NID2 CD93 OIT3 UMODL1 ADGRE1

4.06e-041061696IPR000152
Domain-

UMODL1 WFIKKN1 WFDC5

4.51e-041716934.10.75.10
DomainWAP

UMODL1 WFIKKN1 WFDC5

4.51e-04171693PS51390
DomainCoact_PPARg

FAM120A FAM120C

4.83e-0441692IPR026784
DomainEGF_1

TPO SSPOP PGAP6 THBS1 OIT3 UMODL1 CSPG5 ADGRE1 MUC3A

5.37e-042551699PS00022
DomainEGF-like_CS

TPO NID2 PGAP6 CD93 THBS1 UMODL1 CSPG5 ADGRE1 MUC3A

6.34e-042611699IPR013032
DomainQuino_amine_DH_bsu

NID2 NBAS OLFM1

9.88e-04221693IPR011044
DomainWAP_dom

UMODL1 WFIKKN1 WFDC5

9.88e-04221693IPR008197
DomainPEROXIDASE_1

TPO PXDNL

1.19e-0361692PS00435
DomainIGc2

ADAMTSL1 NFASC PAPLN PTPRF IL1R2 PXDNL WFIKKN1 LRIT1

1.37e-032351698SM00408
DomainIg_sub2

ADAMTSL1 NFASC PAPLN PTPRF IL1R2 PXDNL WFIKKN1 LRIT1

1.37e-032351698IPR003598
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ENGASE FRAS1 MAN2B1 SH2B3 CTC1 FBRSL1 AKNA PAPLN IRF5 INO80 ZZEF1 STK11IP RYR1 TRAK1 GAS2L1 FASN TNRC18 ARHGEF40 NADSYN1 PTPRF ARVCF INF2 KCNH2 AHNAK SUMF1 ANKRD11 TLN2 ZFYVE26 ZNF324B PCNT

8.04e-1411051783035748872
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.32e-125178518755860
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.32e-125178516112031
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.91e-117178511169255
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.84e-108178518681957
Pubmed

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.63e-104178426542066
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

8.19e-1010178512559621
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.50e-0911178519664392
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.55e-0912178520371502
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.55e-0912178519936734
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.55e-0912178519181658
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1

3.30e-095178410424431
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.13e-0913178519934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.13e-0913178519120281
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.13e-0913178518687225
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.40e-0914178519875891
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.40e-0914178519489269
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.40e-0914178519421224
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.40e-0914178515896204
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178520082646
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178519850842
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178520356536
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178519926642
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178520207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178519493232
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178520643584
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178517498266
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.56e-0915178519326408
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1

9.87e-096178417882223
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178519897003
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178519000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178520670355
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178518668235
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178519309280
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178516403292
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178519527230
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178520652381
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178519279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178517868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178518643961
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178520331834
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.39e-0816178520210919
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178519968064
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178520878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178520650299
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178520173784
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178520173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178520483367
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178519218127
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178519169284
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178519450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.95e-0817178519761533
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.69e-0818178519630074
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.69e-0818178520200544
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.69e-0818178519046302
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.69e-0818178520580654
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.69e-0818178520519398
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.69e-0818178519846535
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.64e-0819178518571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.64e-0819178518778326
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.64e-0819178520600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.64e-0819178518848853
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.84e-0820178520193031
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.32e-0821178519861144
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

8.15e-0822178520492596
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3

8.19e-08917847749980
Pubmed

Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.

KIR2DS2 KIR2DL1 KIR2DS1

1.32e-073178329549293
Pubmed

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

KIR2DS2 KIR2DL2 KIR2DL3

1.32e-073178330696053
Pubmed

Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3

1.32e-073178322960345
Pubmed

[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].

KIR2DL1 KIR2DL2 KIR2DL3

1.32e-073178319549382
Pubmed

Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.

KIR2DS2 KIR2DL2 KIR2DS1

1.32e-073178319877200
Pubmed

Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

KIR2DL1 KIR2DL2 KIR2DL3

1.32e-073178315879158
Pubmed

Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients.

KIR2DS2 KIR2DL2 KIR2DS1

1.32e-073178323380384
Pubmed

Imputation of KIR Types from SNP Variation Data.

KIR2DS2 KIR2DL2 KIR2DL3

1.32e-073178326430804
Pubmed

Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.

KIR2DS2 KIR2DL2 KIR2DL3

1.32e-073178318292496
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3

2.13e-0711178418830515
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

FRAS1 MIA3 WAPL MAN2B1 ATR FBRSL1 LARP1 PAPLN ZZEF1 TMEM177 SMYD4 ARHGEF40 FAM120A ARVCF OGFOD1 AP4B1

2.73e-076501781638777146
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1

3.18e-0712178420137308
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.57e-0729178520082482
Pubmed

B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.

KIR2DL1 KIR2DL2 KIR2DL3

5.25e-074178320056126
Pubmed

KIR/HLA ligand incompatibility in kidney transplantation.

KIR2DS2 KIR2DL2 KIR2DL3

5.25e-074178318091530
Pubmed

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.

KIR2DL1 KIR2DL2 KIR2DL3

5.25e-074178325037176
Pubmed

HLA-C and KIR genes in hepatitis C virus infection.

KIR2DL1 KIR2DL2 KIR2DL3

5.25e-074178316571411
Pubmed

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

KIR2DS2 KIR2DL2 KIR2DL3

5.25e-074178316929347
Pubmed

[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].

KIR2DL1 KIR2DL2 KIR2DL3

5.25e-074178318543232
Pubmed

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

KIR2DL1 KIR2DL2 KIR2DL3

5.25e-074178318269867
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1

6.38e-0714178418945962
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

MIA3 TUT4 KIZ MBP TSPYL2 FBRSL1 LARP1 NFASC FAM117B PLD3 CDK14 SSPOP CREBBP TNRC18 NADSYN1 FAM120A INF2 FAM120C MICAL2 VSTM2L ANKRD11 MMP16 FGGY PCNT

6.94e-0714891782428611215
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.51e-0735178519683555
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3

1.31e-06517837716543
Pubmed

Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters.

KIR2DL1 KIR2DL2 KIR2DL3

1.31e-065178312121272
Pubmed

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

KIR2DL1 KIR2DL2 KIR2DL3

1.31e-065178318322206
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.50e-0617178419032228
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3

1.92e-0618178420210918
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1

3.01e-0620178420426625
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

TET2 WAPL FBRSL1 AKNA LARP1 NFASC INO80 CDK14 ZZEF1 TUBGCP6 CDK5RAP2 USP6NL HOMEZ

3.80e-065291781314621295
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DL2

4.54e-067178314607943
Pubmed

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

KIR2DL1 KIR2DL3 KIR2DS1

4.54e-06717839430220
Pubmed

Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.

TBXAS1 ADAMTSL1 VGLL3 TMC2 GLB1L3 EXT1 SORBS1 CREBBP ADCY5 TUBGCP6 CD93 UMODL1 OLFM1 AP4B1 FGGY USP6NL

5.03e-068141781623251661
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

NID2 TUT4 WAPL MAP1A TSPYL2 FBRSL1 ZKSCAN2 INO80 ZZEF1 CREBBP TUBGCP6 ARHGEF40 FAM120A FAM120C SUN2 ZNF324 USP54 SOS1 WDR72

5.07e-0611161781931753913
InteractionTOP3B interactions

ENGASE FRAS1 MAN2B1 SH2B3 CTC1 FBRSL1 AKNA PAPLN IRF5 INO80 ZZEF1 STK11IP RYR1 TRAK1 GAS2L1 FASN TNRC18 ARHGEF40 NADSYN1 FAM120A PTPRF ARVCF INF2 FAM120C KCNH2 AHNAK SUMF1 ANKRD11 TLN2 ZFYVE26 ZNF324B PCNT

9.15e-07147017332int:TOP3B
InteractionKIR2DL2 interactions

KIR2DS2 CD93 KIR2DL1 KIR2DL2

3.53e-06131734int:KIR2DL2
Cytoband19q13.4

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.48e-0579178519q13.4
Cytoband9q34.3

DIPK1B MAMDC4 STPG3 AJM1 OLFM1

6.12e-0510617859q34.3
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.84e-08181055620
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

ADAMTSL1 NFASC PAPLN PTPRF PXDNL WFIKKN1 LRIT1

4.27e-051611057593
GeneFamilyADAM metallopeptidase domain containing|CD molecules

MPL KIR2DS2 CD93 PTPRC IL1R2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.82e-043941059471
GeneFamilyADAMTS like

ADAMTSL1 PAPLN

6.88e-0471052947
GeneFamilyFibronectin type III domain containing

MPL NFASC PTPRC PTPRF LRIT1

2.42e-031601055555
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR2DS2 PVRIG KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.57e-07491776M40909
ToppCellfacs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 BMP2K AKNA IRF5 SSPOP PGAP6 PTPRC ADGRE1

3.18e-0716517688a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14
ToppCelldroplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF13B JCAD ZFP57 CD93 SMYD4 NADSYN1 OIT3 CHRD

7.89e-07186176837860daeecd6d412bd3797f30496a56da667fbd1
ToppCelldroplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF13B JCAD ZFP57 CD93 SMYD4 NADSYN1 OIT3 CHRD

7.89e-07186176860830822d3de3147816693404fd03392e04c2b8e
ToppCelldroplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF13B JCAD ZFP57 CD93 SMYD4 NADSYN1 OIT3 CHRD

7.89e-071861768baebeffdd426ce767190ddefc857cc78e6a58d36
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_alveolar-Dividing_AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

EXT1 PGAP6 XYLT2 MTCP1 MICAL2 SUSD2 USP54 USP6NL

1.36e-062001768befc25cbcbac2c02e5fd33d6e78e59979050090c
ToppCellwk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MPL TBXAS1 TMEM91 GAS2L1 LY6G6F THBS1 PLXNB3

5.23e-061701767eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF13B FRAS1 ANKRD53 PRSS53 FAM151A VSTM2L YLPM1

6.09e-061741767f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellPND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 GAS2L1 LY6G6F THBS1 OIT3 MUC3A

7.07e-0617817679e1f2596fcea5b79cc50b58d83706bb8605e224f
ToppCellPND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 GAS2L1 LY6G6F THBS1 OIT3 MUC3A

7.07e-061781767aa659bd283c4dfbe292cd8698bbf6b1999ca3314
ToppCellPND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 GAS2L1 LY6G6F THBS1 OIT3 MUC3A

7.07e-061781767bf1d273802a4f42e52ea1bd2a0cae2039559c093
ToppCellE18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 SH2B3 MBP GAS2L1 LY6G6F THBS1

7.60e-061801767ca2a35bfb67347e47f511589a3d0f763e6664634
ToppCellE18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 SH2B3 MBP GAS2L1 LY6G6F THBS1

7.60e-0618017674e9e8cde2919610c4ac0025b1c9819808048bc1d
ToppCellE18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 SH2B3 MBP GAS2L1 LY6G6F THBS1

7.60e-061801767466381bf93c3da6a2a241daadb68e9aad2964eae
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TET2 SH2B3 BMP2K ACOD1 CD93 THBS1 AHNAK

8.77e-061841767d1ea2b60fb1ca1a0b809d131310c43903a9e84ce
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

TBXAS1 IRF5 SSPOP CD93 THBS1 MTMR11 ADGRE1

9.41e-061861767a16ecf70271894a842925f232009e2623d16947e
ToppCellmild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TUBGCP6 ARHGEF40 ARVCF IL1R2 YLPM1 OGFOD1 PLEKHA7

9.41e-0618617675b2e1a58916f392fa1156bf9210df528775248ff
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

TBXAS1 MAN2B1 CD93 IL1R2 CHRD TLN2

1.00e-051241766e9b6fdac2bef4bf1fee6a486f4628b68adc80f57
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 VGLL3 NFASC EXT1 SORBS1 THBS1 MICAL2

1.08e-0519017671121eb607a984c59fbffe7220837fc178745aa55
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 VGLL3 NFASC EXT1 SORBS1 THBS1 MICAL2

1.08e-051901767048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

VGLL3 NFASC SORBS1 THBS1 KCNH2 MICAL2 MMP16

1.08e-051901767562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

VGLL3 NFASC SORBS1 THBS1 KCNH2 MICAL2 MMP16

1.08e-051901767f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCellControl-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class

TBXAS1 TET2 EXT1 CD93 THBS1 IL1R2 ANKRD11

1.16e-051921767ad04c9c4bdebf94615cee1904ca48197e62c923b
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

FRAS1 EXT1 CDK14 ANKRD11 PLEKHA7 FGGY WDR72

1.16e-051921767e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPO FRAS1 CWH43 UMODL1 FAM151A KIR2DL1 MMP10

1.20e-051931767315840bc48899f3a36d57b19197509de19716e3d
ToppCellfacs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD MAP1A MBP NFASC SORBS1 INF2 AHNAK

1.37e-051971767a1f7eec1aca03432caa8fe817ff6d24b29d4062d
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

KIF13B MBP NFASC ADCY5 INF2 SUN2 USP54

1.37e-05197176782b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 VGLL3 NFASC EXT1 SORBS1 THBS1 MICAL2

1.37e-0519717679b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 VGLL3 NFASC EXT1 SORBS1 THBS1 MICAL2

1.41e-051981767a860246bcea847249a78fd2e86ed8e04371060db
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Neuron|5w / Sample Type, Dataset, Time_group, and Cell type.

SH2D6 MAP1A PLD3 ZZEF1 MTCP1 WFIKKN1 SUSD2

1.51e-0520017676f3fe94107fa2a2ded4888780b36700cce48adb7
ToppCellHippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)|Hippocampus / BrainAtlas - Mouse McCarroll V32

MPL DPH1 BAAT SSPOP LY6G6F

1.64e-05801765d42b72ef822f731ff5ff1d04216e91f414c5556e
ToppCellHippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

MPL DPH1 BAAT SSPOP LY6G6F

1.64e-05801765d3ee8fc9b2cb47ee476f4cd8b9fcba14cb9ca759
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells)

CPA1 STPG3 TNRC18 MICAL2 CSPG5 CHRD

2.44e-05145176680684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells)

CPA1 STPG3 TNRC18 MICAL2 CSPG5 CHRD

2.44e-051451766cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCellE16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass

TBXAS1 IRF5 PGAP6 PTPRC ADGRE1 PSD4

2.74e-051481766cd5f697d8c2f272be1f3f52a05446749278431c5
ToppCellE16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass

TBXAS1 IRF5 PGAP6 PTPRC ADGRE1 PSD4

2.74e-05148176656e146980a71b5ca655118ae13310c5949220d4a
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

DIP2C-AS1 ZFP57 NFASC SORBS1 ADCY5 KCNH2

3.30e-051531766ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCellIonocyte|World / shred by cell class for nasal brushing

GLT8D2 ZFP57 ADCY5 THBS1 KCNH2 CSPG5

3.42e-0515417666b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

GLT8D2 ADAMTSL1 NFASC SORBS1 ADCY5 CHRD

4.24e-051601766fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCelldroplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 IRF5 PLD3 RYR1 ACOD1 ADGRE1

4.86e-051641766939d4e3911fce185b986639c815de0a0389f6cfd
ToppCelldroplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 IRF5 PLD3 RYR1 ACOD1 ADGRE1

4.86e-0516417663281f2452cc6b11f3e030a3942002b9457dde6fe
ToppCellfacs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MBP AKNA IRF5 RYR1 PTPRC ADGRE1

4.86e-05164176611dfd84f5fb90de330858e1e852848832734e004
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

SH2D6 ALKBH2 AMDHD1 NFASC IL1R2 FGGY

4.86e-051641766d2218d50e0e2d19f919dcb460b3840687c082810
ToppCellfacs-MAT-Fat-18m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 IRF5 ACOD1 PTPRC IL1R2 ADGRE1

5.20e-0516617669116be2805c34881debb999d8417e43832fcf2f2
ToppCellfacs-MAT-Fat-18m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 IRF5 ACOD1 PTPRC IL1R2 ADGRE1

5.20e-0516617665c2667da79935f3d4b1edbfe7a10e7dbc2fa3ad0
ToppCellP15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MARS2 FRAS1 ADAMTSL1 MAP1A MBP TUBGCP6

5.38e-0516717665c3d0763f73628c71c71f9883556bb4f1639f3cc
ToppCellfacs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 ENGASE NID2 ACOD1 ADGRE1 PLXNB3

5.56e-05168176604e168fe1d6f5f9e3d3bf9d7c13e800e3594868a
ToppCelldroplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MBP IRF5 GFPT1 RYR1 PTPRC ADGRE1

5.75e-051691766411556e93adcbb7e4d79b02f3dc72963ec8a0759
ToppCelldroplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MBP IRF5 GFPT1 RYR1 PTPRC ADGRE1

5.75e-05169176639b1acfd099abb9de18c29c05c7a67709ea76775
ToppCelldroplet-Heart-4Chambers-18m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 PTPRC ADGRE1 PSD4

6.13e-0517117664935a95d11ac997d183fab32cbaad837bf0a512b
ToppCellP07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NID2 ADAMTSL1 VGLL3 MBP LY6G6F PLXNB3

6.33e-0517217668d6a2a0d5f63b09a5a304a77e600a647f87e9de4
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC ADGRE1

6.33e-0517217666b01448443cf8392ed8248ff452b80c31240b85d
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC ADGRE1

6.33e-0517217660c0ae2da3cba6022403434567800f16e61a34a2b
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC ADGRE1

6.33e-051721766d80c207f3489be2da2f40f47a7835cb73c949c3e
ToppCellfacs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC OLFM1

6.33e-051721766eaba10a4d4eaab42ad2e2da65ebb20b50edaf815
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ADAMTSL1 SORBS1 ADCY5 PXDNL TLN2 MMP16

6.54e-051731766cb6389536195443633adb06e5f1b7483530773d1
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AKNA CEP128 PTPRC MTCP1 KIR2DL1 KIR2DL3

6.54e-05173176679d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCellfacs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 BMP2K IRF5 PTPRC ADGRE1

6.54e-0517317664e9b6c71030ae0d63d54e7255e4a10b25970fcc4
ToppCellfacs-Heart-LA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 PGAP6 PTPRC ADGRE1

6.75e-05174176630c083fe4711735e83dccfd00fcd746ae673d353
ToppCellfacs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 BMP2K IRF5 PTPRC ADGRE1

6.75e-05174176654166a0faf748cccb6406c2c268e1e6e21caf6d0
ToppCellfacs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 PGAP6 PTPRC ADGRE1

6.75e-05174176646d19c1144fff19be682b7ba59d4c3e014f79e15
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ENGASE DPH1 SH2B3 CD93 IL1R2 ADGRE1

6.75e-051741766eaaf17a06efc09ed4752b449827b1f0f424d3dad
ToppCellfacs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 PGAP6 PTPRC ADGRE1

6.75e-0517417661802a52552256d1e25d8b328ba62dcfe41671900
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TRAK1 PTPRF AHNAK MMP10 PLXNB3 HOMEZ

6.75e-05174176642f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCellfacs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC OLFM1

6.75e-051741766c52aed2ffe9c648e5f23e3459e2d331d6ca214e3
ToppCellfacs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 BMP2K IRF5 PTPRC ADGRE1

6.75e-051741766dc8a238ec1d954bec0f8eb67c04a61734c96f5b5
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TET2 CDK14 GFPT1 TUBGCP6 MICAL2 WFIKKN1

6.97e-051751766c1c722db42da9b8a2a46e516ddb83d9be5e2e504
ToppCellfacs-Heart-LV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 BMP2K IRF5 PTPRC ADGRE1

6.97e-0517517665d106ef542b97f97aeb19179e3f72963ead1e82a
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MARS2 BMP2K TNRC18 INF2 CDK5RAP2 HOMEZ

6.97e-051751766334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCelldroplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TBXAS1 MAN2B1 IRF5 SSPOP RYR1 OLFM1

6.97e-0517517664655d3daa95e8ffa7d5ee4180de06b2fec361bfb
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

MARS2 BMP2K TNRC18 INF2 CDK5RAP2 HOMEZ

6.97e-051751766da191dfb8a7f976a632a3a0b923942ab54f5c8c1
ToppCelldroplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GLB1L3 ZFP57 CD93 THBS1 OIT3 INF2

7.19e-051761766eb63eb2c301e785196ccadac74a2940b2c524c62
ToppCellfacs-Lung-EPCAM-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC OLFM1

7.42e-0517717667bc92314b22a876296a4e2db51e7fb0fdfd69379
ToppCellE16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 GAS2L1 LY6G6F THBS1 INF2

7.42e-05177176684591e28482ab62a5ef41e61043eb64912766356
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

VGLL3 CTC1 MBP SORBS1 KCNH2 PLXNB3

7.42e-05177176659cf56c385c324f0844f20003d2b5049a2791e45
ToppCellE16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 GAS2L1 LY6G6F THBS1 INF2

7.42e-0517717664bc100062891d07cacd10ffba38966cc6302c92f
ToppCellE16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MPL TBXAS1 GAS2L1 LY6G6F THBS1 INF2

7.42e-0517717669f3a2adb9cd4f0a059afc87b6e377a9702154bb1
ToppCelldroplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPL TBXAS1 STK11IP SSPOP LY6G6F FARS2

7.66e-051781766f2002a5c4758d0af6c1880ca12f0af0d5e8888e4
ToppCell5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 TET2 SSPOP RYR1 THBS1 IL1R2

8.14e-05180176666c7b02d85e32ba3e7530d0c4aff17e7525ccdd8
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

ADAMTSL1 SORBS1 ADCY5 PXDNL TLN2 MMP16

8.14e-051801766d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 TSPYL2 NFASC SUSD2 CHRD OLFM1

8.39e-0518117666d1f1ad35778a2a227f966f11f6edd8e89452576
ToppCellwk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MPL TBC1D15 GLB1L3 SORBS1 LY6G6F PLXNB3

8.39e-051811766724efbc200e8388829bc7d81830c2689a95fa838
ToppCellfacs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GLT8D2 MAP1A TMEM91 MANEAL CDK5RAP2 USP6NL

8.65e-051821766be9c312a44868d4ee266a64d066feb8c5bce5687
ToppCellfacs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC OLFM1

8.65e-0518217669465238ac806fce46dfe1a141e83893f23eb4afb
ToppCellfacs-Lung-Endomucin-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GLT8D2 MAP1A TMEM91 MANEAL CDK5RAP2 USP6NL

8.65e-05182176674dbb706bcaa0f8c922bf3b0424bce5bb27167fa
ToppCelldroplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MBP NFASC ZKSCAN2 CSPG5 MMP16 PLXNB3

8.65e-051821766a512863304fad80acaab60a8c6107eb7c9cbac99
ToppCellfacs-Lung-EPCAM-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 MBP IRF5 RYR1 PTPRC OLFM1

8.92e-051831766f524501dec1dccbf44100a61395116e4525bdc89
ToppCell3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TPO JCAD DIPK1B SLC6A2 CD93 CLEC19A

9.19e-051841766842473fa415575441b595073a994b6d621169776
ToppCellCOPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class

TBXAS1 TET2 EXT1 CD93 THBS1 IL1R2

9.19e-051841766ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCellfacs-Liver-Non-hepatocytes-3m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VGLL3 GRAMD1A AKNA DIPK1B PTPRC SLC25A53

9.19e-0518417668fc047977fad38fcd26eebcc279a688efd342ed8
ToppCellfacs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TBXAS1 MAN2B1 IRF5 RYR1 PTPRC OLFM1

9.47e-051851766ed7b26bdebfd0df2b4f5020a855a052d94ae7219
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

JCAD PHF24 MBP EXT1 INF2 OLFM1

9.75e-05186176656c139e679d640ea901ead657a8e8887e0fca098
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MBP SORBS1 LY6G6F CSPG5 MMP16 PLXNB3

9.75e-051861766d8d559daff4aeef334d403fde4e3ee2e4a6086d0
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ZFP57 ZZEF1 IL1R2 FARS2 MICAL2 FGGY

1.00e-0418717664527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCellAT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

FRAS1 MICAL2 SUSD2 VSTM2L CSPG5 MUC3A

1.00e-041871766f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NID2 MBP SORBS1 LY6G6F KCNH2 PLXNB3

1.00e-0418717668e8b147258982b359447add5027318f5b6d51963
ToppCellControl-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

TET2 EXT1 CD93 THBS1 IL1R2 ANKRD11

1.03e-04188176647126c371a242c937499fd278a74a882df8f759c
ToppCellCOPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class

TBXAS1 TET2 EXT1 CD93 THBS1 IL1R2

1.06e-041891766d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCellIPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class

TBXAS1 FAM117B EXT1 PTPRC UMODL1 ADGRE1

1.06e-0418917665c22d2d935f7bb270260b8bc6be67b565ec401bf
ToppCellFetal_29-31_weeks-Immune-natural_killer_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MBP AKNA PTPRC SUN2 KIR2DL1 KIR2DL3

1.06e-041891766c604da558c9f4055fb36218452463539f2a73223
ToppCellAT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

PGAP6 FASN PTPRF MICAL2 SUSD2 FGGY

1.06e-0418917662d32f09efa982ae458568f6b1cd06bb5078d42a3
DrugFluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A

SH2B3 BMP2K IRF5 TRAK1 MTMR11 CLCN2 KCNH2 FGGY SOS1 PSD4

3.12e-06196176107348_DN
DrugOxethazaine [126-27-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A

ENGASE MAP1A BAAT SPAG6 THBS1 OVGP1 KCNH2 ZNF324 FGGY PSD4

3.42e-06198176101484_UP
DiseasePrimary Myelofibrosis

MPL TET2 SH2B3

3.58e-0661683C0001815
DiseasePolycythemia Vera

MPL TET2 SH2B3

9.94e-0681683C0032463
Diseasediastolic blood pressure, unipolar depression

SH2B3 TRAK1 SLC6A2 EIF4G2

2.48e-05301684EFO_0003761, EFO_0006336
DiseaseN-acetylputrescine measurement

SLC6A2 TUBGCP6 EIF4G2

3.84e-05121683EFO_0800127
DiseaseThrombocythemia, Essential

MPL TET2 SH2B3

3.84e-05121683C0040028
Diseaseresponse to thiazide, QT interval

ADAMTSL1 CREBBP

9.63e-0531682EFO_0004682, EFO_0007981
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR2DL1 KIR2DL3

9.63e-0531682OBA_2042107
DiseaseSeckel syndrome 1

ATR PCNT

9.63e-0531682C4551474
Diseasepulse pressure measurement

TBXAS1 TET2 JCAD FBRSL1 IRF5 DELE1 INO80 CDK14 SSPOP ADCY5 TMEM91 TRAK1 FASN ARVCF PXDNL ANKRD11 TLN2 PLEKHA7 FGGY HOMEZ

1.36e-04139216820EFO_0005763
Diseasesporadic amyotrophic lateral sclerosis

TBXAS1 ADAMTSL1 WAPL NFASC SUMF1 ZFYVE26

1.56e-041401686EFO_0001357
DiseaseChronic myeloproliferative disorder

MPL ATR PCNT

1.64e-04191683C1292778
DiseaseMYELOFIBROSIS

MPL SH2B3

1.92e-0441682254450
DiseasePrimary myelofibrosis

MPL SH2B3

1.92e-0441682cv:C0001815
DiseaseMyelofibrosis

MPL TET2

1.92e-0441682C0026987
DiseaseX-15461 measurement

SLC6A2 EIF4G2

1.92e-0441682EFO_0800749
Diseasedecreased fine motor function

SLC6A2 EIF4G2

3.19e-0451682EFO_0010132
DiseaseX-24020 measurement

TUBGCP6 KCNH2

3.19e-0451682EFO_0022128
DiseaseEssential thrombocythemia

MPL SH2B3

3.19e-0451682cv:C0040028
DiseaseX-13215 measurement

SLC6A2 EIF4G2

3.19e-0451682EFO_0021347
Diseasemental or behavioural disorder, attempted suicide

JCAD SORBS1

3.19e-0451682EFO_0000677, EFO_0004321
Diseasereticulocyte count

ATR SH2B3 BMP2K SEM1 GRAMD1A ZFP57 LARP1 FAM117B TMEM91 ARSA PTPRC MICAL2 AHNAK TLN2 PLEKHA7 HOMEZ

3.29e-04104516816EFO_0007986
Diseaseessential thrombocythemia (is_implicated_in)

MPL SH2B3

4.76e-0461682DOID:2224 (is_implicated_in)
Diseaseindole-3-propionate measurement

SLC6A2 NBAS EIF4G2

4.80e-04271683EFO_0010501
Diseasecystatin C measurement

SH2B3 KIZ IRF5 FAM117B CD93 NBAS ANKRD11 SOS1 WDR72

5.22e-044021689EFO_0004617
DiseaseMYELODYSPLASTIC SYNDROME

MPL TET2 SH2B3 CTC1

5.88e-04671684C3463824
Diseasehepatitis C virus infection, cirrhosis of liver

GLT8D2 PKD1L1

6.64e-0471682EFO_0001422, EFO_0003047
Diseasemyelofibrosis (is_implicated_in)

MPL SH2B3

8.82e-0481682DOID:4971 (is_implicated_in)
Diseasevitamin D measurement, vitamin D dietary intake measurement

AMDHD1 NADSYN1

8.82e-0481682EFO_0004631, EFO_0008539
Diseasehepatitis C (is_marker_for)

MPL IRF5 KIR2DS1

1.04e-03351683DOID:1883 (is_marker_for)
Diseasecorticobasal degeneration disorder

KIF13B SOS1

1.13e-0391682MONDO_0022308
Disease5-acetylamino-6-formylamino-3-methyluracil measurement

SLC6A2 EIF4G2

1.13e-0391682EFO_0800950
Diseasesleep latency

FRAS1 SLC6A2 EIF4G2

1.22e-03371683EFO_0005280
Diseaseglomerulosclerosis (implicated_via_orthology)

INF2 PLEKHA7

1.71e-03111682DOID:0050851 (implicated_via_orthology)
Disease5-acetylamino-6-amino-3-methyluracil measurement

SLC6A2 EIF4G2

1.71e-03111682EFO_0800951
Diseasebeta-nerve growth factor measurement

FASN SUMF1 TLN2

1.77e-03421683EFO_0008035
DiseaseHematologic Neoplasms

MPL SH2B3

2.05e-03121682C0376545
DiseaseN-acetyltaurine measurement

SLC6A2 EIF4G2

2.41e-03131682EFO_0020023
Diseasecryptic phenotype measurement

SH2B3 CHRNA4 KCNH2

2.45e-03471683EFO_0021487
DiseaseMetabolic Bone Disorder

CTC1 ANKRD11

2.80e-03141682C0005944
DiseasePneumoconiosis

ATR OVGP1

2.80e-03141682C0032273
DiseaseBagassosis

ATR OVGP1

2.80e-03141682C0004681
Diseaseupper aerodigestive tract neoplasm

ZFP57 ZKSCAN2 CHRNA4 SLC6A2 PTPRF EIF4G2

2.94e-032461686EFO_0004284
DiseaseLeukemia, Myelocytic, Acute

TET2 SH2B3 CTC1 CREBBP GAS2L1

3.19e-031731685C0023467
Disease1,3,7-trimethylurate measurement

FRAS1 PTPRF

3.22e-03151682EFO_0021172
DiseaseOsteopenia

CTC1 ANKRD11

3.22e-03151682C0029453
Diseasemyelodysplastic syndrome (implicated_via_orthology)

TET2 CREBBP

3.22e-03151682DOID:0050908 (implicated_via_orthology)
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR2DL1 KIR2DL3

3.22e-03151682EFO_0801746
Diseaseplatelet crit

MPL TET2 JCAD USP30 MAP1A SH2B3 ADCY5 THBS1 ARHGEF40 PTPRC ARVCF YLPM1 CHRD

3.25e-0395216813EFO_0007985
DiseaseMalignant neoplasm of breast

TBXAS1 NID2 ERCC3 SYT3 SORBS1 SPAG6 MAMDC4 RNF115 THBS1 FASN PTPRC ZFYVE26 USP54 MMP10

3.45e-03107416814C0006142
Diseaseamygdala volume change measurement

PKD1L1 FGGY

3.67e-03161682EFO_0021490
Diseasebone fracture

SEM1 EXT1 AHNAK SUMF1

3.91e-031121684EFO_0003931
Diseasesystemic lupus erythematosus, COVID-19

MARS2 ZFP57 IRF5

4.45e-03581683MONDO_0007915, MONDO_0100096
Diseaseglucuronate measurement

IL1R2 WDR72

4.64e-03181682EFO_0010486
Diseasesuperior frontal gyrus volume measurement

SYT3 GRAMD1A

4.64e-03181682EFO_0010329
Diseasebirth weight, parental genotype effect measurement

TET2 SH2B3 ZFP57 INO80 ADCY5

4.95e-031921685EFO_0004344, EFO_0005939
DiseaseSystemic Scleroderma

IRF5 XYLT2

5.17e-03191682C0036421
Diseasealcohol use disorder (implicated_via_orthology)

FBRSL1 CREBBP CHRNA4 RYR1 PSD4

5.28e-031951685DOID:1574 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
PSPTEDPTGHFLWHA

UMODL1

646

Q5DID0
HSAGPSWRHIRAEGL

ALKBH2

51

Q6NS38
LLDPTDPLAWGHSAH

MAMDC4

696

Q6UXC1
SSVHGLPSPHEAWNR

FBRSL1

721

Q9HCM7
AHLFHDGRVQWTPPA

CHRNA4

141

P43681
RLHWGGEVIPHAAAQ

BAAT

381

Q14032
GPDIHYDPHRWLAES

CEP128

856

Q6ZU80
ELGGHRDPSPSHWVE

ARHGEF40

661

Q8TER5
LHSPQHWRPRSLGAG

LINC00588

46

Q9Y4M8
GDFGKGLEPWERHHP

ANKRD11

991

Q6UB99
HEVIVPHSGWEREPN

ARVCF

491

O00192
LPPARWNSSGEGHLE

CTC1

166

Q2NKJ3
PTSRWHAVPPQHTLG

CSPG5

316

O95196
WINAHGLRDPSVPTG

ALDH16A1

451

Q8IZ83
LSPRNPHSWGIKAHG

DNAH10OS

71

P0CZ25
VPNAGHWIHADRPQD

ABHD11

291

Q8NFV4
EHLQLDFWRGPAHPG

CPA1

46

P15085
EAAHWARPAPQFHGL

AJM1

211

C9J069
PGVWREPSIHHATAA

CD93

541

Q9NPY3
AHQQVLPWRGEFHPD

AP4B1

641

Q9Y6B7
APPSSTGVRKGWHEH

CREBBP

581

Q92793
ISAPDVDVHGPDWHL

AHNAK

1366

Q09666
INAPDVDVHGPDWHL

AHNAK

3586

Q09666
TPNEDTWPGVHSLPH

CDK14

351

O94921
SIGHNPPHWGAERPF

ADCY5

666

O95622
TEGVPHGAWHAAALP

DIPK1B

231

Q5VUD6
LGPWTVNHGQDRRPH

DPH1

391

Q9BZG8
SPDLSWHPPHQGLSD

BMP2K

1076

Q9NSY1
WHPPHQGLSDIRADH

BMP2K

1081

Q9NSY1
KRPLSWRAHGDGPQH

GRAMD1A

556

Q96CP6
EHRPENLHGVPGWQA

CDK5RAP2

906

Q96SN8
QPGVHGPWTELETHG

ITPKC

166

Q96DU7
PDHQTLSHRLPWAEG

ITPKC

646

Q96DU7
LQGAWPHEGVHRKPS

KIR2DS2

16

P43631
PALDWDSVHVPGPHA

PTPN9

271

P43378
LHQLRSWGAPEGESH

INO80

926

Q9ULG1
PSPPTLHGDEHLSWF

LY6G6F

36

Q5SQ64
LHTVDGHWVAPVPRL

ANKRD53

436

Q8N9V6
RSHWNPEPEFHLISA

MMP10

316

P09238
LEHGHVEWSSRGPPN

OGFOD1

311

Q8N543
SHPHRFWPAIDDGLR

PLD3

336

Q8IV08
RHSSNPPLESHVGWV

LARP1

821

Q6PKG0
LQGAWPHEGVHRKPS

KIR2DL2

16

P43627
PDHGHVLWRQTASEP

FRAS1

2001

Q86XX4
VWFPHELDGQGARPH

MAP1A

1706

P78559
LQGAWPHEGVHRKPS

KIR2DL3

16

P43628
GPRLSWHHPGGSDLL

MTMR11

256

A4FU01
LGRAHPSQPRFNWSH

GLB1L3

41

Q8NCI6
QAHSLPVHVREGPWE

JCAD

141

Q9P266
PAHDTNHRGPPTSWL

KCNH2

141

Q12809
HCEAIGHPRPTISWA

ADAMTSL1

1201

Q8N6G6
RWTVPELLTHPGIHA

C9orf131

766

Q5VYM1
GLAGPHLVPVGWESH

PLXNB3

686

Q9ULL4
GTHAPVWLNGSHPLE

OIT3

81

Q8WWZ8
NSPHSRDLAGWPLGV

MUC3A

46

Q02505
ASFQEHPDLPGLWLH

TPO

506

P07202
TDNFTSHRLPHPWSG

OLFM1

286

Q99784
SHRLPHPWSGTGQVV

OLFM1

291

Q99784
GRHKPWDFPSVHNDL

GLT8D2

316

Q9H1C3
SEIAPTRPRWNTHGH

TUBGCP6

1041

Q96RT7
DVAPTRPRWNIHGHV

TUBGCP6

1096

Q96RT7
PTRPRWNTHGHVSNA

TUBGCP6

1126

Q96RT7
VAPTRPRWNTHGHVS

TUBGCP6

1151

Q96RT7
APTRPRWNTHGHVSD

TUBGCP6

1206

Q96RT7
AFWPGHIAPGVTHEL

ARSA

316

P15289
ASFHWSLLGPEHPLA

FAM120A

251

Q9NZB2
PWRHATRHGPSQDGD

IRF5

46

Q13568
SHPAPGDWFVAAHLP

PGAP6

146

Q9HCN3
SPWEGVSDHLAHREP

KIZ

341

Q2M2Z5
EHHWVPRKAFLDNGP

EIF4G2

306

P78344
RHTGRKQPPVSESHW

NBAS

1081

A2RRP1
LGHEWRLEPSEGHSQ

PCNT

631

O95613
WAESPPADDHHVQRT

PCNT

2291

O95613
QVDHGLGSAWVPSHR

INF2

541

Q27J81
VSWAHLETGIFPPGH

LRIT1

176

Q9P2V4
LHPDELFPHGESWGD

NID2

31

Q14112
ETINLEWDHPEHPNG

NFASC

946

O94856
HPHPLITWTRDNGLE

PXDNL

356

A1KZ92
HRVLPDHPWGTLNPS

C6orf15

201

Q6UXA7
NGPGHQLWRRFPEHV

ATR

1436

Q13535
SGRNGLHHPSPDHFW

EXT1

41

Q16394
PGHWGIHLQIAEPAA

FAM151A

406

Q8WW52
LHVWPDFHGNRSPLA

FGGY

386

Q96C11
PSGPAELGTWHALHS

GAS2L1

656

Q99501
VFPNLHVPEDRPGWH

GALNT4

431

Q8N4A0
HVPEDRPGWHGAIRS

GALNT4

436

Q8N4A0
APYLAGHWPRDSHGQ

FAM117B

226

Q6P1L5
HHQPEWGNPNRDRGS

FAM120C

546

Q9NX05
WDPHPQPDGHQDSES

AKNA

71

Q7Z591
PGLVDAHTHPVWAGE

AMDHD1

81

Q96NU7
SPEAWAHLLTPNGPH

MANEAL

276

Q5VSG8
DGRPRVAWHIDPFGH

MAN2B1

186

O00754
AWQDAHPADPGSRPH

MBP

76

P02686
DTWHPATHPSGAVLP

ACOD1

96

A6NK06
NGESPKHRSWHTLTP

KLHDC1

241

Q8N7A1
IPPVGWTNTAHRHGV

ENGASE

171

Q8NFI3
HTSRPLWVAPDGHIF

ERCC3

71

P19447
HLEPAWPQGLRHNSV

HOMEZ

326

Q8IX15
GHPDARQLWDSPETA

FHOD1

476

Q9Y613
GLWAPNLHFHSPNPE

FASN

351

P49327
WTGHVARPVTSPGQH

RYR1

721

P21817
LQGAWPHEGVHRKPS

KIR2DL1

16

P43626
VAAEHRHSSGLPYWP

NPIPB6

236

E9PJ23
HDSRGPSPGWFISHV

PKD1L1

1866

Q8TDX9
GPQRVEHCSWHSPLD

DELE1

111

Q14154
IGSNHRDPHPIWGKD

MICAL2

1386

O94851
RRPPNAWHKHNTDAG

PTPRF

456

P10586
WAHSRPGPASILPHD

OVGP1

31

Q12889
LQGAWPHEGVHRKPS

KIR2DS1

16

Q14954
TPSLHSRHWGAPQQR

PEX16

181

Q9Y5Y5
VSLVSRWAVSGHPHP

CWH43

216

Q9H720
SSPIQLHHGDRILWG

KIF13B

521

Q9NQT8
RVGPDAADPHGREHW

SYT3

536

Q9BQG1
LEGNPLWFHPEHRAA

STK11IP

286

Q8N1F8
LHESSGIHDIGLPQW

SLC6A2

221

P23975
HSFPRAGTWLAVHPN

SUSD2

136

Q9UGT4
GHQTHTDFWGARPPR

RNF115

106

Q9Y4L5
PPHHGLDSKWDTRVT

SMYD4

276

Q8IYR2
AAWALGQIGRHTPEH

SPAG6

356

O75602
HLGRPHLPGSEWQEA

SSPOP

4991

A2VEC9
GLVVDWDHHLPPPAA

RNF181

41

Q9P0P0
WTPHTSVEPGHSDKR

MIA3

906

Q5JRA6
IAHTRWATHGEPSPV

GFPT1

91

Q06210
VGAPPDHLWVHQEGI

MTCP1

6

P56278
RQDAPPWGSGVELTH

PSD4

101

Q8NDX1
TWLHPRTGEPVNSGH

PLEKHA7

36

Q6IQ23
WHPLPLVDRHSGSRE

SH2D6

151

Q7Z4S9
PAQRARGPWIHESKH

SEM1

36

Q6ZVN7
QRETGCLGPSWLPHH

MRGPRG-AS1

126

Q2M3A8
CLGPSWLPHHQGRDE

MRGPRG-AS1

131

Q2M3A8
WLPHHQGRDEELSLS

MRGPRG-AS1

136

Q2M3A8
WGPQGHLHLPRSGTT

DIP2C-AS1

191

Q8N8Z3
LSPVGPHTLGHRWAA

SLC25A53

106

Q5H9E4
SSPPTVEWHISRPGH

SOS1

756

Q07889
DPEHRGHIEWPDFLS

PHF24

256

Q9UPV7
RTGKADGLTVLWPHH

IL1R2

376

P27930
ANWRHPEGPDSTILH

SUMF1

186

Q8NBK3
RPDHPVLHVSWNDAV

SUMF1

201

Q8NBK3
PHWTPDHVTGEGIDT

ATPSCKMT

191

Q6P4H8
HSWEGHIRPTRKPNT

ADGRE1

16

Q14246
WHSNRLLGDCGPHTP

COA6

21

Q5JTJ3
LTHPSGEVWGPLIRH

CHRD

261

Q9H2X0
PGIPADVWTGLHDHR

CLEC19A

101

Q6UXS0
EVHALWGPHSRHGLP

CLCN2

871

P51788
HDDWLHTPLISPDAN

TRAK1

66

Q9UPV9
PDHHLPDGERGWVLG

PRSS53

406

Q2L4Q9
AAHLATHPWLPRSGN

TNRC18

796

O15417
LHLSWGPTERVHDGR

WFDC5

141

Q8TCV5
GALHHDPEHWPSPET

TBXAS1

436

P24557
TPGQVRTLWHDPRHI

THBS1

1086

P07996
GQLPPELQSWGVHHL

USP6NL

371

Q92738
HGWTLPAHASQPSPR

nan

51

Q8NFD4
PHRLLGGQEPSTWDE

ZNF324

231

O75467
VSHSTPIRWHRGQEP

TSPYL2

336

Q9H2G4
EEWKHGGDQSPPRIH

ZFP57

411

Q9NU63
HFDSDEPWTLGNPNH

MMP16

221

P51512
HESWFPPRSSLEELH

SUN2

76

Q9UH99
WAAQEHPSARGDHRG

PAPLN

576

O95428
PAGHNLLGPATEWNH

STPG3

316

Q8N7X2
LPGDPGHILTTLDHW

TOMT

91

Q8WZ04
QRWPHHSQPARASGS

SORBS1

216

Q9BX66
SESPGEPRHHSWIAK

WDR72

1081

Q3MJ13
NARHWNHPDSEELPG

WAPL

556

Q7Z5K2
SESLPHWGSELGLPH

SH2B3

486

Q9UQQ2
LPTPNLHWREISSGH

MPL

391

P40238
SRRSSHLHWGIPVPG

MARS2

256

Q96GW9
HLHWGIPVPGDDSQT

MARS2

261

Q96GW9
WTQAPKERGHRGSEH

TBC1D15

76

Q8TC07
APWNHGEERGHEEFP

YLPM1

1191

P49750
SPHLVLWHYDPQRGG

WFIKKN1

311

Q96NZ8
TSLWSDGGPHRIDHQ

TEX13A

341

Q9BXU3
EDPQHLGEWGHLDPA

ZSCAN18

221

Q8TBC5
ELELEASWPTHPHRN

ZZEF1

1261

O43149
PKDPPTWSVLAGHSH

TLN2

1626

Q9Y4G6
WFHGRHLGAIPPESG

UBR7

161

Q8N806
SPVHREKHSPLGAAW

ZKSCAN2

136

Q63HK3
EELQSWVRGHHPKSG

ZNF232

106

Q9UNY5
PAATWGHPLTLDHCL

USP30

256

Q70CQ3
PDSGHAPSQTHPWRS

TMC2

881

Q8TDI7
RPAGHAPWDNHVSGH

VSTM2L

26

Q96N03
AADPSPWPGHNLHQT

VGLL3

181

A8MV65
GHQHQAWGSRPPAAE

FARS2

26

O95363
PVVIHGHTVDWRSPA

TMEM177

121

Q53S58
AIPNTSHDGHWPRTV

TUT4

1541

Q5TAX3
SHDGHWPRTVAPNSL

TUT4

1546

Q5TAX3
PERAHPEVNGDTKWH

TET2

41

Q6N021
PTHAAHRPQGPAAWA

PVRIG

261

Q6DKI7
FTSWPDHGVPEDPHL

PTPRC

816

P08575
AQWLLTSHPRGAHGP

ZFYVE26

2521

Q68DK2
QHPEEPLEGTTWTHS

TMEM251

76

Q8N6I4
LRKDDASWLHAGPPH

XYLT2

756

Q9H1B5
WDGGSRLSPFLPHDH

TMEM91

81

Q6ZNR0
HHSWEPLDAPEGKLQ

USP54

986

Q70EL1
PHRLLGGQEPSTWDE

ZNF324B

231

Q6AW86
GSEICEELWTPHSPH

NADSYN1

171

Q6IA69
LGDHVWLEPPSTHKT

MYO7B

6

Q6PIF6